Consumer Misuse of Cosmeceuticals and Its Role in Adverse Skin Reactions

Year : 2026 | Volume : 03 | Issue : 02 | Page : 1 16
    By

    Suraj Sen,

  • Anit Jha,

  • Praveen Yadav,

  • Shah Mohmmed,

  • Vikash Prajapati,

  • Ajay Kumar,

  1. Principal, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  2. Academic Head, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  3. Assistant Professor, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  4. Scholar, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  5. Scholar, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  6. Scholar, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India

Abstract

Cosmeceuticals represent a rapidly expanding category of products positioned between cosmetics and pharmaceuticals, offering both aesthetic and therapeutic benefits. However, their widespread availability, aggressive marketing, and perception as inherently safe have contributed to increasing instances of consumer misuse. Misuse includes over-application, inappropriate combinations, prolonged unsupervised use, and use of high-potency active ingredients without dermatological guidance. Such practices have been strongly associated with a broad spectrum of adverse cutaneous reactions ranging from mild irritation to severe dermatological conditions such as steroid-induced dermatitis, exogenous ochronosis, and contact dermatitis. Recent literature highlights that commonly used ingredients such as hydroquinone, retinoids, alpha-hydroxy acids (AHAs), and topical corticosteroids are frequently implicated in adverse outcomes when misused. The growing trend of self-medication, especially in skin-lightening and anti-aging regimens, exacerbates the risk. Furthermore, sociocultural influences, including beauty standards and digital media promotion, play a significant role in shaping unsafe consumer behavior. This review critically examines patterns of cosmeceutical misuse, identifies high-risk ingredients, and explores the mechanisms underlying adverse skin reactions. It also discusses regulatory challenges and proposes preventive strategies aimed at improving consumer awareness and dermatological safety. Understanding these factors is essential for healthcare professionals, pharmacists, and regulatory authorities to mitigate risks and promote rational cosmeceutical use.

Keywords: Cosmeceuticals, Misuse, Adverse Skin Reactions, Hydroquinone, Retinoids, Topical Steroids, Dermatotoxicity, Skin Irritation, Consumer Behavior, Cosmetovigilance

[This article belongs to International Journal of Toxins and Toxics ]

How to cite this article:
Suraj Sen, Anit Jha, Praveen Yadav, Shah Mohmmed, Vikash Prajapati, Ajay Kumar. Consumer Misuse of Cosmeceuticals and Its Role in Adverse Skin Reactions. International Journal of Toxins and Toxics. 2026; 03(02):1-16.
How to cite this URL:
Suraj Sen, Anit Jha, Praveen Yadav, Shah Mohmmed, Vikash Prajapati, Ajay Kumar. Consumer Misuse of Cosmeceuticals and Its Role in Adverse Skin Reactions. International Journal of Toxins and Toxics. 2026; 03(02):1-16. Available from: https://journals.stmjournals.com/ijtt/article=2026/view=244455


References

1. Bandyopadhyay D. Topical treatment of melasma. Indian journal of dermatology. 2009 Oct
1;54(4):303-9.
2. Callender VD, Barbosa V, Burgess CM, Heath C, McMichael AJ, Ogunleye T, Taylor SC.
Approach to treatment of medical and cosmetic facial concerns in skin of color patients. Cutis.
2017 Dec 1;100(6):375-80.
3. Chohan SN, Suhail M, Salman S, Bajwa UM, Saeed M, Kausar S, Suhail T. Facial abuse of
topical steroids and fairness creams: a clinical study of 200 patients. Journal of Pakistan
Association of Dermatologists. 2014;24(3):204-11.
4. Dadzie OE, Petit A. Skin bleaching: highlighting the misuse of cutaneous depigmenting
agents. Journal of the European Academy of Dermatology and Venereology. 2009
Jul;23(7):741-50.
5. Duarte I, Lazzarini R, Kobata C, Rotter A. Dermatological drugs, topical agents, and
cosmetics. InSide Effects of Drugs Annual 2009 Jan 1 (Vol. 31, pp. 287-295). Elsevier.
6. Gonçalo M. Phototoxic and photoallergic contact reactions. InContact Dermatitis 2020 Oct 13
(pp. 365-389). Cham: Springer International Publishing.
7. Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds:
medical and psychosocial aspects. Dermatologic Clinics. 2011 Jan 1;29(1):111-23.
8. Li Y, Li L. Contact dermatitis: classifications and management. Clinical reviews in allergy &
immunology. 2021 Dec;61(3):245-81.
9. Lim HW, Zhang C, Taylor M, Dlova NC, Conceição K, Jablonski N, Gupta N, Wangari‐Olivero
J, Alexis A. International expert consensus on knowledge gaps in care for dermatologic
disorders in skin of color. International Journal of Dermatology. 2026 Jan;65(1):41-56.
10. Lim HW, Zhang C, Taylor M, Dlova NC, Conceição K, Jablonski N, Gupta N, Wangari‐Olivero
J, Alexis A. International expert consensus on knowledge gaps in care for dermatologic
disorders in skin of color. International Journal of Dermatology. 2026 Jan;65(1):41-56.
11. Zirwas MJ. Contact dermatitis to cosmetics. Clinical Reviews in Allergy & Immunology. 2019
Feb 15;56(1):119-28.

Regular Issue Subscription Review Article
Volume 03
Issue 02
Received 04/05/2026
Accepted 10/05/2026
Published 20/05/2026
Publication Time 16 Days
26

Login


My IP

PlumX Metrics